We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Possibilities in Vision for Neurosurgery

By HospiMedica staff writers
Posted on 15 May 2007
Two new intraoperative fluorescence technologies allow surgeons to monitor the success of the procedure with fluorescence-based visualization methods, enabling them to make well-founded decisions when it matters most--during surgery. More...


Infrared 800 is an efficient technique that delivers critical information quickly and conveniently to the surgeon without procedural disruption, optimizing the overall operating workflow. This fluorescence option enables better recognition of blood flow, and is specially tailored to the requirements of vascular neurosurgery both for the treatment of vascular diseases, such as cerebral aneurysms or arteriovenous malformations (AVMs), and for bypass operations. For these procedures, vessel blood flow must be monitored before and confirmed after surgery to ensure the surgical progress.

Blue 400 facilitates precise definition of tumor margins during fluorescence-based malignant brain tumor resection and the removal of tissue. In the treatment of malignant brain tumors, the primary difficulty lies in distinguishing between tumor margins and healthy tissue under standard surgical conditions. During the removal of the malignant tumor tissue, vital and functional areas of the brain must be preserved to ensure that the patient's quality of life is not impaired. Blue 400 serves as an excellent aid for visualizing tumors clearly and precisely at any time during the procedure. The malignant tissue glows red in the Blue 400 mode, allowing the surgeon to recognize and treat the tumor margins more effectively.

"The opportunity to have an angiogram that is so easy and allows you to manipulate the vessels or the aneurysm, while you are performing it, is incredibly exciting to neurosurgeons,” said Robert F. Spetzler, M.D., chairman and medical director of the Barrow Neurological Institute (Phoenix, AZ, USA).

Blue 400 and Infrared 800, developed by Carl Zeiss Meditec (Oberkochen, Germany), have been integrated into a single system in the Zeiss output module interface (OPMI) Pentero surgical microscope, designed for use in neurosurgery, ear nose and throat (ENT) surgery, and spine surgery.


Related Links:
Carl Zeiss Meditec

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.